Skip to content

NNRTIs have a greater risk of resistance than PIs when used in regimens after treatment break

Risk of peripheral neuropathy five times higher for common genetic group

US men's study finds cumulative NRTI use, but not PIs or NNRTIs, associated with insulin resistance

Panacos announces results of first agent in new drug class

Routine lactate monitoring warranted only in those at risk, concludes Swiss study

Directly observed therapy shown to be of value for some patients

Ranbaxy says seven ARV products are back on WHO list

High proportion of HIV-positive patients obese or overweight

Race does not affect effectiveness of HAART: US women's study